Market Recap — April 16, 2026

Auditor Issues Going Concern Warning Amidst Internal Control Weaknesses, Debt Default, and Significant Financial Deterioration

$1.5B All-Share AI Acquisition Transforms Diginex, Targets $280M Revenue by 2027

583% Surge: Allbirds Pivots from Footwear to AI, Secures $50M Funding Days Before Collapse

Director's Affiliates Make $11.4M Open Market Share Purchases, Reinforcing Insider Confidence

QVC Group Files for Chapter 11 Bankruptcy, Confirms Equity Worthlessness in Restructuring Plan

Ingles Markets Accuses Activist Nominee Rory Held of Sackler Family Conflicts, Urges Vote Against

Director Mark Strome Invests $600K in HeartBeam Public Offering Amidst Going Concern Warning

CEO Consolidates Control with Significant Share Purchase and Rescinds Prior Agreement

Kailera Therapeutics Prices IPO at $16/Share, Raising $625M Ahead of Nasdaq Debut

OrbiMed Advisors, a Director, Invests $3.75M in ImageneBio Private Placement

Grupo Aval Reports 69.6% Net Income Growth and 9.6% ROAE for 2025 Amid Strategic Acquisitions and Macroeconomic Headwinds

ConnectM Discloses Going Concern Doubt, Nasdaq Delisting, and 1-for-32 Reverse Stock Split in Annual Report

10% Owner Kenneth Dart Continues Accumulation with $7.9M Total Return Swap Purchase

Director and 10% Owner Gregg Williams Buys Nearly $2 Million in Vivani Medical Stock

Director Mark Strome Invests $600K in HeartBeam Public Offering Amidst Going Concern Warning

Executive Chair Buys $264K in Stock Following Going Concern Warning

CEO Buys $198K in Shares Following 'Going Concern' Warning, Signaling Confidence

Director Willem Elfrink Buys $150K in HeartBeam Public Offering Amidst Insider Cluster

10% Owner HRT Financial LP Buys $127K in Onconetix Shares Amidst Going Concern Doubts

Director Milton C. Ault, III Makes Significant Open Market Purchase of ALZN Shares

Director Richard Ferrari Buys $50K in HeartBeam Public Offering Amidst Going Concern

Director Sells $22.9M in Pre-Planned Transactions as Stock Nears 52-Week High

Directors and 10% Owners Sell $18.6M in Redwire Corp Shares Amid Ongoing Distribution

10% Owner Harraden Circle Investors Sells $6.6M in Suncrete Stock Post-Business Combination

10% Owner Saba Capital Sells $1.8M in Vertical Aerospace Shares

10% Owner and Former CEO Sells $270K in Meridian Holdings Stock

10% Owner Sells $140K in Rocky Mountain Chocolate Factory Shares Amid Financial Concerns

$1.5B All-Share AI Acquisition Transforms Diginex, Targets $280M Revenue by 2027

583% Surge: Allbirds Pivots from Footwear to AI, Secures $50M Funding Days Before Collapse

QVC Group Files for Chapter 11 Bankruptcy, Confirms Equity Worthlessness in Restructuring Plan

Kailera Therapeutics Prices IPO at $16/Share, Raising $625M Ahead of Nasdaq Debut

LifeVantage Appoints Terrence Moorehead as CEO, Details Substantial Compensation

Aspire Biopharma Closes $21 Million Highly Dilutive Preferred Stock Offering to Meet Nasdaq Listing Requirements

Revolution Medicines Secures $2.15B in Capital, Upsizing Stock Offering to $1.65B

Revolution Medicines Closes $1.65B Equity Offering, Secures $500M Convertible Notes for $2.14B Total Capital Raise

NEONC Technologies Secures $13M Financing, Clarifies Financials, and Sets Key Clinical Milestones Amidst CEO Stock Purchase

Rainmaker Worldwide Inc. Fails to File Annual Report, Enters Non-Compliance with SEC Reporting Obligations

Officer Ryan Gerbrandt Files Intent to Sell Over $1 Million in Shares Following Option Exercise

10% Stockholder Files Intent to Sell $18.17M in Redwire Shares

Significant Owner Files Intent to Sell Additional $26.1 Million in Shares

Director Files Intent to Sell Over $1.2 Million in AEHR Stock Amidst Financial Weakness

Former Director Files Intent to Sell $6.95M in Stock, Following $16.8M in Recent Sales

Officer Michael Saks Files Intent to Sell Additional Shares